vaccine

News

Trailing its RSV vaccine rivals, Bavarian Nordic cuts China ...

Bavarian Nordic has licensed rights to its respiratory syncytial virus (RSV) vaccine in China and certain other Asian markets to Shanghai's Nuance Pharma in a $225 million deal.

Events

Partner Content

Welcome to the 2nd Chronic HBV Drug Development Summit

Advance Combination Therapies, Outline Clinical Endpoints & Understand the Immunology Perspective to Achieve Functional Cures for Chronic Hepatitis B.

R&D

Does the pandemic mark a turning point in vaccine developmen...

After a period where vaccine development had fallen away, suddenly it is back in the limelight.

News

After GSK stumble, Pfizer moves forward with RSV vaccine

Pfizer has been awarded breakthrough status from the FDA for its respiratory syncytial virus (RSV) vaccine in pregnant women, putting the company in pole position to bring a shot to market

News